These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 15087130

  • 1. Cloning and functional characterization of PELP1/MNAR promoter.
    Mishra SK, Balasenthil S, Nguyen D, Vadlamudi RK.
    Gene; 2004 Apr 14; 330():115-22. PubMed ID: 15087130
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
    Nair SS, Mishra SK, Yang Z, Balasenthil S, Kumar R, Vadlamudi RK.
    Cancer Res; 2004 Sep 15; 64(18):6416-23. PubMed ID: 15374949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y, Chen S.
    Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940
    [Abstract] [Full Text] [Related]

  • 6. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D, Masri S, Ye JJ, Chen S.
    Gene; 2005 Nov 21; 361():89-100. PubMed ID: 16181749
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
    Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC.
    J Cell Biochem; 2003 Oct 01; 90(2):315-26. PubMed ID: 14505348
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J, Ather JL, Sonstegard TS, Kerr DE.
    Gene; 2005 Jun 20; 353(1):107-17. PubMed ID: 15935571
    [Abstract] [Full Text] [Related]

  • 11. Activation of bone morphogenetic protein-6 gene transcription in MCF-7 cells by estrogen.
    Zhang M, Yan JD, Zhang L, Wang Q, Lü SJ, Zhang J, Zhu TH.
    Chin Med J (Engl); 2005 Oct 05; 118(19):1629-36. PubMed ID: 16232348
    [Abstract] [Full Text] [Related]

  • 12. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B, Dossing DA, Dimuzio MT.
    J Bone Miner Res; 1995 May 05; 10(5):769-81. PubMed ID: 7639112
    [Abstract] [Full Text] [Related]

  • 13. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z, Reierstad S, Huang CC, Bulun SE.
    Cancer Res; 2007 May 15; 67(10):5017-24. PubMed ID: 17510434
    [Abstract] [Full Text] [Related]

  • 14. Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
    Glaeser M, Niederacher D, Djahansouzi S, Hanstein B, Dittrich R, Beckmann MW, Fasching PA, Ackermann S.
    Anticancer Res; 2006 May 15; 26(1B):735-44. PubMed ID: 16739346
    [Abstract] [Full Text] [Related]

  • 15. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N, Zhao X, Tang H, Jaffe RB, Speed TP, Leitman DC.
    Endocrinology; 2007 Jul 15; 148(7):3449-58. PubMed ID: 17395694
    [Abstract] [Full Text] [Related]

  • 16. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
    Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE.
    Gynecol Oncol; 2006 Nov 15; 103(2):417-24. PubMed ID: 16690106
    [Abstract] [Full Text] [Related]

  • 17. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
    Gionet N, Jansson D, Mader S, Pratt MA.
    J Cell Biochem; 2009 Jun 01; 107(3):448-59. PubMed ID: 19350539
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
    Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2010 Jun 15; 70(12):5174-83. PubMed ID: 20501845
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O, Yamagishi T, Hanada K, Kawashima H.
    Biochem Biophys Res Commun; 2001 Dec 07; 289(3):705-11. PubMed ID: 11726205
    [Abstract] [Full Text] [Related]

  • 20. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
    Vadlamudi RK, Balasenthil S, Broaddus RR, Gustafsson JA, Kumar R.
    J Clin Endocrinol Metab; 2004 Dec 07; 89(12):6130-8. PubMed ID: 15579769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.